Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 muta...

por Teshima, Yasutomo, Kizaki, Minako, Kurihara, Ryohei, Kano, Ryosuke, Harumiya, Miki
Publicado 2020

Ceritinib in Japanese patients with anaplastic lymphoma kinase (ALK)+ non-small cell lung cancer: interim analysis results of a post-marketing surveillance study

por Kaneda, Hiroyasu, Kizaki, Minako, Ochi, Masami, Shiraiwa, Naoko, Akatsu, Shigemi
Publicado 2020